Purpose: The focus of this educational exhibit is to present a concise review of transarterial chemoembolization (TACE) in the treatment of hepatocellular carcinoma (HCC).Material and Met...
Purpose: The focus of this educational exhibit is to present a concise review of percutaneous ablation of spinal tumors.Material and Methods: We present a review of percutaneous ablation ...
Purpose: The focus of this educational exhibit is to present a concise review of percutaneous irreversible electroporation (IRE) in the treatment of pancreatic adenocarcinoma.Material and...
The focus of this educational exhibit is to present a concise review of the utility of percutaneous cryoablation (PCA) in the treatment of renal cell carcinoma (RCC).
Purpose: The focus of this educational exhibit is to present a concise review of the utility of thermal ablation in the treatment of papillary thyroid carcinoma (PTC).Material and Methods...
Purpose: To evaluate accuracy and safety of scout dose yttrium-90 (Y90) resin microspheres vs. technetium-99m (Tc99m) macroaggregated albumin (MAA) in predicting the therapeutic dose Y90 ...
Purpose: To evaluate the feasibility of intranodal CT lymphangiography (ICTL) imaging for diagnosis and planning of subsequent intervention in patients with thoracic lymphatic disorders.
...
Purpose: Conventional CT-guided percutaneous microwave ablation (pMWA) of hepatic tumors that are small or exhibit similar attenuation as the background liver parenchyma can be technicall...
Purpose: Transarterial chemoembolization (TACE) is an important tool in the hands of interventional oncologists. However, TACE is limited to particle embolics or lipiodol slurries, with c...
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
Transit Scientific Press Release
Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular
procedures, proudly announces the successful debut of XO...
Transit Scientific Press Release
Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular
procedures, proudly announces the successful debut of XO...
Siemens Healthineers and University Hospitals Cleveland News
Siemens Healthineers and University H...
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.
Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.
Embolization is a minimally invasive...
